Gastrointestinal motility and the brain-gut axis

Digestive Endoscopy

Volumn 15, Issue 2, 2003, Pages 81-86

  Ishiguchi, Tadashi ^a   Itoh, Hidekazu ^a   Ichinose, Masao ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Brain gut axis; Gastroesophageal reflux disease; Gastrointestinal motility; Irritable bowel syndrome; Non ulcer dyspepsia

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; BOMBESIN; CLEBOPRIDE; CLONIDINE; CORTICOTROPIN RELEASING FACTOR; METOCLOPRAMIDE; MORPHINE; NEUROPEPTIDE Y; NOCICEPTIN; PROTIRELIN; SALCATONIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; DISEASE ASSOCIATION; DYSPEPSIA; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY; HUMAN; INTESTINE TRANSIT TIME; IRRITABLE COLON; LOWER ESOPHAGUS SPHINCTER; MOUSE; NONHUMAN; REGULATORY MECHANISM; REVIEW; STOMACH EMPTYING;

EID: 0141918538     PISSN: 09155635     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1443-1661.2003.00222.x     Document Type: Review

References (89)

1. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994; 107: 271-93.
2. Sander R, Frankenberger U. The use of endoscopy in patients with gastrointestinal motility problems. J. Clin. Gastroenterol. 2001; 33: 185-90.
3. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig. Dis. Sci. 1993; 38: 1590-5.
4. MacIntosh DG, Thompson WG, Patel DG, Barr R, Guindi M. Is rectal biopsy necessary in irritable bowel syndrome? Am. J. Gastroenterol. 1992; 87: 1407-9.
5. Roze C. Neurohumoral control of gastrointestinal motility. Reprod. Nutr. Dev. 1980; 20: 1125-41.
6. Kirchgessner AL, Liu M. Orexin synthesis and response in the gut. Neuron 1999; 24: 941-51.
7. Diamant NE. Overview of functional gut disorders: a challenge. Scand. J. Gastroenterol. 1995; 213(Suppl.): 1-6.
8. Bakke HK. CNS effects on gastric functions: from clinical observations to peptidergic brain-gut interactions. J. Physiol. Paris 1993; 87: 265-71.
9. Clouse RE. Psychiatric disorders in patients with esophageal disease. Med. Clin. North Am. 1991; 75: 1081-96.
10. Bradley LA, Richter JE, Pulliam TJ et al. The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am. J. Gastroenterol. 1993; 88: 11-9.
11. Baker LH, Lieberman D, Oehlke M. Psychological distress in patients with gastroesophageal reflux disease. Am. J. Gastroenterol. 1995; 90: 1797-803.
12. Wiklund I, Butler-Wheelhouse P. Psychosocial factors and their role in symptomatic gastroesophageal reflux disease and functional dyspepsia. Scand. J. Gastroenterol. 1996; 220(Suppl.): 94-100.
13. Stanghellini V. Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand. J. Gastroenterol. 1999; 231(Suppl.): 29-37.
14. Song CW, Lee SJ, Jeen YT et al. Inconsistent association of esophageal symptoms, psychometric abnormalities and dysmotility. Am. J. Gastroenterol. 2001; 96: 2312-6.
15. Mittal RK, Stewart WR, Ramahi M, Chen J, Tisdelle D. The effects of psychological stress on the esophagogastric junction pressure and swallow-induced relaxation. Gastroenterology 1994; 106: 1477-84.
16. Penagini R, Bartesaghi B, Bianchi PA. Effect of cold stress on postprandial lower esophageal sphincter competence and gastroesophageal reflux in healthy subjects. Dig. Dis. Sci. 1992; 37: 1200-5.
17. Lidums I, Lehmann A, Checklin H, Dent J, Holloway RH. Control of transient lower esophageal sphincter relaxations and reflux by the GABA (B) agonist baclofen in normal subjects. Gastroenterology 2000; 118: 7-13.
18. Park H, Conklin JL. Neuromuscular control of esophageal peristalsis. Curr. Gastroenterol. Rep. 1999; 1: 186-97.
19. Rossiter CD, Norman WP, Jain M, Hornby PJ, Benjamin S, Gillis RA. Control of lower esophageal sphincter pressure by two sites in dorsal motor nucleus of the vagus. Am. J. Physiol. 1990; 259: G899-906.
20. McDermott CM, Abrahams TP, Partosoedarso E et al. Site of action of GABA (B) receptor for vagal motor control of the lower esophageal sphincter in ferrets and rats. Gastroenterology 2001; 120: 1749-62.
21. Blackshaw LA, Smid SD, O'Donnell TA, Dent J. GABA (B) receptor-mediated effects on vagal pathways to the lower oesophageal sphincter and heart. Br. J. Pharmacol. 2000; 130: 279-88.
22. Washabau RJ, Fudge M, Price WJ, Barone FC. GABA receptors in the dorsal motor nucleus of the vagus influence feline lower esophageal sphincter and gastric function. Brain Res. Bull. 1995; 38: 587-94.
23. Kawakami H, Hongo M, Okuno Y, Yamada M, Nishimura N, Fukudo S. Personality deviation and gastric motility in patients with functional dyspepsia. J. Clin. Gastroenterol. 1995; 21(Suppl. 1): S179-84.
24. Lee S, Park M, Choi S, Nah Y, Abbey SE, Rodin G. Stress, coping, and depression in non-ulcer dyspepsia patients. J. Psychosom. Res. 2000; 49: 93-9.
25. Soo S, Moayyedi P, Deeks J, Delaney B, Lewis M, Forman D. Psychological interventions for non-ulcer dyspepsia. Cochrane Database System Review 2001; CD: 002301.
26. Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000; 16: 1009-12.
27. Inui A, Okano H, Miyamoto M et al. Delayed gastric emptying in bulimic patients. Lancet 1995; 346: 1240.
28. Tache Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am. J. Physiol. Gastrointest. Liver Physiol. 2001; 280: G173-7.
29. Koo MW, Ogle CW, Cho CH. The effect of cold-restraint stress on gastric emptying in rats. Pharmacol. Biochem. Behav. 1985; 23: 969-72.
30. Diop L, Pascaud X, Junien JL, Bueno L. CRF triggers the CNS release of TRH in stress-induced changes in gastric emptying. Am. J. Physiol. 1991; 260: G39-44.
31. Kacker V, Mehta VS, Gupta YK. Acute intracranial hypertension-induced inhibition of gastric emptying: evaluation in conscious rats. Eur J. Pharmacol. 1999; 369: 65-72.
32. Improta G, Broccardo M. Effect of selective mu 1, mu 2 and delta 2 opioid receptor agonists on gastric functions in the rat. Neuropharmacology 1994; 33: 977-81.
33. Costall B, Gunning SJ, Naylor RJ, Simpson KH. A central site of action for benzamide facilitation of gastric emptying. Eur J. Pharmacol. 1983; 91: 197-205.
34. Porreca F, Burks TF. Centrally administered bombesin affects gastric emptying and small and large bowel transit in the rat. Gastroenterology 1983; 85: 313-7.
35. Garrick T, Veiseh A, Tache Y, Weiner H. Corticotropin-releasing factor acts on the brain to reduce gastric contractility. Psychother. Psychosom. 1987; 48: 14-20.
36. Smedh U, Kaplan JM, Uvnas-Moberg K. Corticotropin-releasing factor-induced suppression of gastric emptying in the rat is blocked by cyclo (7-aminoheptanoyl-phe-D-TRP-LYS-THR[BZL], an in vivo somatostatin antagonist. Neurosci. Lett. 1999; 260: 41-4.
37. Ishiguchi T, Amano T, Matsubayashi H, Tada H, Fujita M, Takahashi T. Centrally administered neuropeptide Y delays gastric emptying via Y2 receptors in rats. Am. J. Physiol. Regul. Integ. Comp. Physiol. 2001; 281: R1522-30.
38. Tache Y, Kolve E, Maeda-Hagiwara M, Kauffman GL Jr. Central nervous system action of calcitonin to alter experimental gastric ulcers in rats. Gastroenterology 1988; 94: 145-50.
39. Martinez V, Barrachina MD, Wang L, Tache Y. Intracerebroventricular leptin inhibits gastric emptying of a solid nutrient meal in rats. Neuroreport 1999; 10: 3217-21.
40. Ozawa M, Aono M, Moriga M. Central effects of pituitary adenylate cyclase activating polypeptide (PACAP) on gastric motility and emptying in rats. Dig. Dis. Sci. 1999; 44: 735-43.
41. Imeryuz N, Yegen BC, Bozkurt A, Coskun T, Villanueva-Penacarrillo ML, Ulusoy NB. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am. J. Physiol. 1997; 273: G920-7.
42. Asakawa A, Inui A, Yuzuriha H et al. Cocaine-amphetamine-regulated transcript influences energy metabolism, anxiety and gastric emptying in mice. Hormone Metab. Res. 2001; 33: 554-8.
43. Flanagan LM, Olson BR, Sved AF, Verbalis JG, Stricker EM. Gastric motility in conscious rats given oxytocin and an oxytocin antagonist centrally. Brain Res. 1992; 578: 256-60.
44. Hornby PJ, Rossiter CD, Pineo SV et al. TRH. immunocytochemical distribution in vagal nuclei of the cat and physiological effects of microinjection. Am. J. Physiol. 1989; 257: G454-62.
45. Feng HS, Lynn RB, Han J, Brooks FP. Gastric effects of TRH analogue and bicuculline injected into dorsal motor vagal nucleus in cats. Am. J. Physiol. 1990; 259: G321-6.
46. Lynn RB, Feng HS, Han J, Brooks FP. Gastric effects of thyrotropin-releasing hormone microinjected into the dorsal vagal nucleus in cats. Life Sci. 1991; 48: 1247-54.
47. Hornby PJ, Rossiter CD, White RL, Norman W, Kuhn DH, Gillis RA. Medullary raphe: a new site for vagally mediated stimulation of gastric motility in cats. Am. J. Physiol. 1990; 258: G637-47.
48. Heymann-Monnikes I, Tache Y, Trauner M, Weiner H, Garrick T. CRF microinjected into the dorsal vagal complex inhibits TRH analog- and kainic acid-stimulated gastric contractility in rats. Brain Res. 1991; 554: 139-44.
49. White RL Jr, Rossiter CD, Hornby PJ, Harmon JW, Kasbekar DK, Gillis RA. Excitation of neurons in the medullary raphe increases gastric acid and pepsin production in cats. Am. J. Physiol. 1991; 260: G91-6.
50. Garrick T, Yang H, Trauner M, Livingston E, Tache Y. Thyrotropin-releasing hormone analog injected into the raphe pallidus and obscurus increases gastric contractility in rats. Eur J. Pharmacol. 1992; 223: 75-81.
51. Panico WH, Cavuto NJ, Kallimanis G et al. Functional evidence for the presence of nitric oxide synthase in the dorsal motor nucleus of the vagus. Gastroenterology 1995; 109: 1484-91.
52. Krowicki ZK, Sharkey KA, Serron SC, Nathan NA, Hornby PJ. Distribution of nitric oxide synthase in rat dorsal vagal complex and effects of microinjection of nitric oxide compounds upon gastric motor function. J. Comp. Neurol. 1997; 377: 49-69.
53. Davison JS, Pearce CM. Actions of intrahypothalamic NPY on gastric function. Proc. West Pharmacol. Soc. 1997; 40: 135-6.
54. Krowicki ZK, Arimura A, Hornby PJ. Opposite gastric motor effects of PACAP38 and VIP when microinjected into the nucleus raphe obscurus of rats. Ann. N.Y. Acad. Sci. 1996; 805: 655-60.
55. Talman WT, Andreasen K, Calvin J et al. Cholecystokinin in nucleus tractus solitarii modulates tonic and phasic gastric pressure. Am. J. Physiol. 1991; 261: R217-22.
56. Hermann G, Rogers RC. Tumor necrosis factor-alpha in the dorsal vagal complex suppresses gastric motility. Neuroimmunomodulation 1995; 2: 74-81.
57. Hermann GE, Tovar CA, Rogers RC. Induction of endogenous tumor necrosis factor-alpha: suppression of centrally stimulated gastric motility. Am. J. Physiol. 1999; 276: R59-68.
58. Emch GS, Hermann GE, Rogers RC. TNF-alpha activates solitary nucleus neurons responsive to gastric distension. Am. J. Physiol. Gastrointest. Liver Physiol. 2000; 279: G582-6.
59. Krowicki ZK, Nathan NA, Hornby PJ. Cyclooxygenase inhibition in the dorsal vagal complex of the rat evokes increases in gastric motor function. J. Physiol. Paris 1997; 91: 209-13.
60. Sivarao DV, Krowicki ZK, Abrahams TP, Hornby PJ. Intracisternal antisense oligonucleotides to TRH receptor abolish TRH-evoked gastric motor excitation. Am. J. Physiol. 1997; 272: G1372-81.
61. Ishiguchi T, Takahashi T, Itoh H, Owyang C. Nitrergic and purinergic regulation of the rat pylorus. Am. J. Physiol. Gastrointest. Liver Physiol. 2000; 279: G740-7.
62. Ishiguchi T, Nakajima M, Sone H, Tada H, Kumagai AK, Takahashi T. Gastric distension-induced pyloric relaxation: central nervous system regulation and effects of acute hyperglycaemia in the rat. J. Physiol. 2001; 533: 801-13.
63. Monnikes H, Tebbe J, Bauer C, Grote C, Arnold R. Neuropeptide Y in the paraventricular nucleus of the hypothalamus stimulates colonic transit by peripheral cholinergic and central CRF pathways. Neurogastroenterol. Motil. 2000; 12: 343-52.
64. Chaudhary HR. Study of intestinal transit time in patient with anxiety and depression. J. Assoc. Phys. India 1989; 37: 156-7.
65. Stewart JJ. Interactions of reserpine and morphine on rat intestinal transit. J. Pharmacol. Exp. Ther. 1981; 216: 521-5.
66. Tadano T, Kisara K, Stewart JJ. A comparison of peripheral and central effects of clonidine on rat intestinal transit. Res. Commun. Chem. Pathol. Pharmacol. 1992; 78: 161-79.
67. Hamada S, Kawane T, Akeno N, Igarashi H, Horiuchi N. Regulation of small intestinal transit by central nervous calcitonin receptor. Hormone Metab. Res. 1999; 31: 499-504.
68. Fargeas MJ, Fioramonti J, Bueno L. Central and peripheral action of GABAA and GABAB agonists on small intestine motility in rats. Eur. J. Pharmacol. 1988; 150: 163-9.
69. Fukudo S, Nomura T, Muranaka M, Taguchi F. Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. A preliminary study. J. Clin. Gastroenterol. 1993; 17: 133-41.
70. Towers AL, Burgio KL, Locher JL, Merkel IS, Safaeian M, Wald A. Constipation in the elderly: influence of dietary, psychological, and physiological factors. J. Am. Geriatr. Soc. 1994; 42: 701-6.
71. Farthing MJ. Irritable bowel syndrome: new pharmaceutical approaches to treatment. Baillieres Best Pract. Res. Clin. Gastroenterol. 1999; 13: 461-71.
72. Wald A. Irritable Bowel Syndrome. Curr. Treat. Options Gastroenterol. 1999; 2: 13-9.
73. Whitehead WE, Palsson OS. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology 1998; 115: 1263-71.
74. Jarrett M, Heitkemper M, Cain KC et al. The relationship between psychological distress and gastrointestinal symptoms in women with irritable bowel syndrome. Nurs. Res. 1998; 47: 154-61.
75. Bennett EJ, Tennant CC, Piesse C, Badcock CA, Kellow JE. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 1998; 43: 256-61.
76. Lustyk MK, Jarrett ME, Bennett JC, Heitkemper MM. Does a physically active lifestyle improve symptoms in women with irritable bowel syndrome? Gastroenterol. Nurs. 2001; 24: 129-37.
77. Nomura T, Fukudo S, Matsuoka H, Hongo M. Abnormal electroencephalogram in irritable bowel syndrome. Scand. J. Gastroenterol. 1999; 34: 478-84.
78. Blomhoff S, Jacobsen MB, Spetalen S, Dahm A, Malt UF. Perceptual hyperreactivity to auditory stimuli in patients with irritable bowel syndrome. Scand. J. Gastroenterol. 2000; 35: 583-9.
79. Houghton LA. Sensory dysfunction and the irritable bowel syndrome. Baillieres Best Pract. Res. Clin. Gastroenterol. 1999; 13: 415-27.
80. Drossman DA. Review article: an integrated approach to the irritable bowel syndrome. Aliment Pharmacol. Ther. 1999; 13(Suppl. 2): 3-14.
81. Williams CL, Peterson JM, Villar RG, Burks TF. Corticotropin-releasing factor directly mediates colonic responses to stress. Am. J. Physiol. 1987; 253: G582-6.
82. Haga K, Asano K, Fukuda T, Kobayakawa T. The function of 5-HT3 receptors on colonic transit in rats. Obes. Res. 1995; 3(Suppl. 5): 801S-10S.
83. Osinski MA, Bass P, Gaumnitz EA. Peripheral and central actions of orphanin FQ (nociceptin) on murine colon. Am. J. Physiol. 1999; 276: G125-31.
84. Takahashi T, Bagnol D, Schneider D et al. Orphanin FQ causes contractions via inhibiting purinergic pathway in the rat colon. Gastroenterology 2000; 119: 1054-63.
85. Koslo RJ, Burks TF, Porreca F. Centrally administered bombesin affects gastrointestinal transit and colonic bead expulsion through supraspinal mechanisms. J. Pharmacol. Exp. Ther. 1986; 238: 62-7.
86. Monnikes H, Schmidt BG, Raybould HE, Tache Y. CRF in the paraventricular nucleus mediates gastric and colonic motor response to restraint stress. Am. J. Physiol. 1992; 262: G137-43.
87. Monnikes H, Schmidt BG, Tache Y. Psychological stress-induced accelerated colonic transit in rats involves hypothalamic corticotropin-releasing factor. Gastroenterology 1993; 104: 716-23.
88. Greenwood B, DiMicco JA. Activation of the hypothalamic dorsomedial nucleus stimulates intestinal motility in rats. Am. J. Physiol. 1995; 268: G514-21.
89. Monnikes H, Tebbe J, Grote C et al. Involvement of CCK in the paraventricular nucleus of the hypothalamus in the CNS regulation of colonic motility. Digestion 2000; 62: 178-84.